How Genetics Shape Type 1 Diabetes Risk Across Asian Populations

Type 1 diabetes has a strong genetic component. Recent large-scale genomic studies in Asian populations are revealing new details about which genes increase diabetes risk and how those patterns differ around the world. This knowledge is helping researchers understand why Type 1 diabetes appears more commonly in some populations than others—and how we might better predict and manage the disease across different groups.

Type 1 diabetes is an autoimmune condition, meaning the immune system mistakenly attacks insulin-producing cells. This process is heavily influenced by genes related to immune function. Researchers have identified specific HLA (human leukocyte antigen) and non-HLA immune-related genetic variants that affect Type 1 diabetes risk.

Interestingly, Asian populations show lower rates of Type 1 diabetes compared to European and other ancestry groups. Recent studies suggest this difference may be partly explained by population-specific immune-related genetic variants that are more or less common in Asian people. Environmental factors, including exposure to certain infections, may also play a role in these differences.

Scientists have developed tools called polygenic risk scores (PRS) that combine information from many genetic variants to estimate someone's likelihood of developing diabetes. These scores show promise for identifying people at higher risk so they can receive closer monitoring or targeted interventions.

However, there is a significant limitation: most genetic research and risk prediction tools have been developed using data from people of European ancestry. When these tools are applied to Asian or other non-European populations, they are often less accurate. This disparity means that people from diverse ancestry backgrounds may not get the same level of personalized risk assessment.

To address these gaps, researchers emphasize the need to expand genomic studies across East, Southeast, and South Asia. By building larger genetic databases that reflect the diversity of Asian populations and working across different biobank resources, scientists can develop more accurate risk prediction tools tailored to different ancestry groups.

Researchers also suggest using ancestry-matched approaches and considering how different genetic pathways work together—for example, taking into account immune-related genes alongside metabolic factors. These refined approaches could ultimately lead to better health equity, ensuring that people across all populations benefit from advances in genetic medicine and personalized diabetes care.

Source: Journal of diabetes investigation. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.